You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study

Article metrics

Article menu

Download PDFPDF

Crystal arthropathies
Original article
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study

 

Online download statistics by month:

Online download statistics by month: April 2018 to September 2024

AbstractFullPdf
Apr 201814415338
May 2018525415
Jun 2018616215
Jul 2018353519
Aug 2018272710
Sep 2018232313
Oct 201827278
Nov 201820207
Dec 201815154
Jan 201921193
Feb 201920198
Mar 201917176
Apr 201921212
May 201929298
Jun 201913124
Jul 201925243
Aug 201923222
Sep 201925253
Oct 201923235
Nov 201925245
Dec 201928256
Jan 202025254
Feb 202024249
Mar 202022225
Apr 202016161
May 202017173
Jun 202026261
Jul 202025243
Aug 202013123
Sep 202033286
Oct 202032308
Nov 202017155
Dec 202021204
Jan 202117165
Feb 2021171211
Mar 202123203
Apr 202119167
May 2021313111
Jun 202128265
Jul 202117134
Aug 20211091
Sep 202116144
Oct 202117156
Nov 2021574
Dec 20219103
Jan 20228112
Feb 2022793
Mar 202213133
Apr 202216161
May 202229286
Jun 202223210
Jul 2022851
Aug 202221213
Sep 202223201
Oct 202221145
Nov 20221187
Dec 2022642
Jan 202312138
Feb 202317161
Mar 2023730
Apr 2023876
May 2023869
Jun 202318162
Jul 202311106
Aug 2023333
Sep 2023564
Oct 2023990
Nov 2023994
Dec 2023661
Jan 202411117
Feb 202416116
Mar 202419197
Apr 2024161510
May 202417166
Jun 202422165
Jul 202421199
Aug 20246550
Sep 2024975
Total15901517483